Japanese scientists published a research report in the latest issue of the American journal Stem Cells, indicating that endometrial blood can be used to cultivate myocardial cells to repair cardiac injury, and its success rate is 100 times higher than the 0.2% to 0.3% achieved by using bone marrow stem cells.